ONDANSETRON
NDC 63629-4306, ONDANSETRON, tablet, orally disintegrating, from Bryant Ranch Prepack.
- Product NDC
- 63629-4306
- Status
- Listed
- Labeler
- Bryant Ranch Prepack
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA077557
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63629-4306 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ONDANSETRON8 mg/1
Pharmacologic classes
Serotonin 3 Receptor Antagonists [MoA]; Serotonin-3 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63629-4306-0 | 63629430600 | 3 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (63629-4306-0) |
| 63629-4306-1 | 63629430601 | 30 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (63629-4306-1) |
| 63629-4306-2 | 63629430602 | 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (63629-4306-2) |
| 63629-4306-3 | 63629430603 | 5 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (63629-4306-3) |
| 63629-4306-4 | 63629430604 | 4 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (63629-4306-4) |
| 63629-4306-5 | 63629430605 | 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (63629-4306-5) |
| 63629-4306-6 | 63629430606 | 14 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (63629-4306-6) |
| 63629-4306-7 | 63629430607 | 60 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (63629-4306-7) |
| 63629-4306-8 | 63629430608 | 12 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (63629-4306-8) |
| 63629-4306-9 | 63629430609 | 90 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (63629-4306-9) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/384a5cfb-05dd-2b79-73f4-a01a47a9eb3e
Use it
Look up 63629-4306 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63629-4306 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63629-4306. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.